CHD3 p.Arg1706Trp
c.5116C>T · rs903965338 · VCV2439977
Computational evidence
| Protein change | ||
| AlphaMissense | 0.5896 | likely pathogenic |
|---|---|---|
| REVEL | 0.673 | pathogenic-leaning |
| SaProt | LLR -10.87 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · C>A here scores Δ0.81 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 2.1 | GERP 0.56, phastCons 0.95 |
| Regional constraint | o/e 0.95 | unconstrained · MANE · 1,113 bp · p 0.44 · regional, not allelic |
| Overall | ||
| CADD | 25.5 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.00321% | 31,167 |
| East Asiangrpmax | 0.00223% | 44,788 |
| Finnishnot grpmax-eligible | 0.00156% | 64,002 |
| African / African-American | 0.00134% | 74,810 |
| European (non-Finnish) | 0.000764% | 130,865 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CHD3
- Protein
- p.Arg1706Trp
- Coding
- c.5116C>T
- MANE Select
- NM_001005273
- dbSNP
- rs903965338
- Type
- single nucleotide variant
- Location
- chr17:7907983 (GRCh38)
- Gene constraint
- LOEUF 0.257 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 63.21
- Residue 1706
- the 'disordered' region; the 'required for interaction with pcnt' region; a UniProt-annotated variant site (in snibcps)
Similar variants
- CHD3 p.Arg1706Gln Uncertain significance ★ ⚠ same residue
- CHD3 c.4073-2A>C Likely pathogenic ★★ same condition
- CHD3 p.Arg1078Gln Pathogenic/Likely pathogenic ★★ same condition
- CHD3 p.Arg1121Pro Pathogenic/Likely pathogenic ★★ same condition
- CHD3 p.Arg1169Gln Pathogenic/Likely pathogenic ★★ same condition
- CHD3 p.Arg1169Pro Pathogenic/Likely pathogenic ★★ same condition
- CHD3 p.Arg1169Trp Pathogenic ★★ same condition
- CHD3 p.Arg1172Gln Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/chd3-p-arg1706trp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown